Strain Information | |
---|---|
Image | |
BRC No. | RBRC10971 |
Type | Targeted Mutation Congenic![]() |
Species | Mus musculus |
Strain name | B6.Cg-Serpinh1<tm1Kzn> |
Former Common name | Hsp47 +/- |
H-2 Haplotype | |
ES Cell line | E14 [129P2/OlaHsd] |
Background strain | |
Appearance | |
Strain development | Developed by Kazuhiro Nagata, Kyoto University in 2000. E14 ES cells derived from 129P2/OlaHsd were used. C57BL/6 congenic strain by backcrossing over 21 generations. |
Strain description | Serpinh1 (Hsp47) knockout mice. Exon 4 was replaced with the Neo gene cassette. |
Colony maintenance | |
References | Embryonic lethality of molecular chaperone hsp47 knockout mice is associated with defects in collagen biosynthesis. Nagai N, Hosokawa M, Itohara S, Adachi E, Matsushita T, Hosokawa N, Nagata K J. Cell Biol. 150(6):1499-506 (2000). 10995453 |
Health Report | |
---|---|
Examination Date / Room / Rack |
Gene | |||||||
---|---|---|---|---|---|---|---|
Gene Symbol | Gene Name | Chr. | Allele Symbol | Allele Name | Common Names | Promoter | Diseases Related to This Gene |
Serpinh1 MGI:88283 | serine (or cysteine) peptidase inhibitor, clade H, member 1 | 7 | Serpinh1<tm1Kzn> MGI:2385994 | targeted mutation 1, Kazuhiro Nagata | |||
neo | neomycin resistance gene (E. coli) | 7 | herpes simplex virus thymidine kinase promoter (HSV tk promoter) | ||||
SV40 polyA signal | 7 |
Phenotype | |
---|---|
Annotation by Mammalian phenotyhpe ontology | |
Detailed phenotype data |
Ordering Information | |
---|---|
Donor DNA | Herpes Simplex virus (HSV) Thymidine kinase (TK) promoter, E. coli Neomycin resistant gene, SV40 polyA signal, mouse Serpinh1 genomic DNA |
Research application | |
Specific Term and Conditions | In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. J. Cell Biol. 150(6):1499-506 (2000).In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. For use of the BIOLOGICAL RESOURCE by a for-profit institution, the RECIPIENT must reach agreement on terms and conditions of use of it with DEPOSITOR and must obtain a prior written consent from the DEPOSITOR. The RECIPIENT must contact the DEPOSITOR in the case of application for any patents or commercial use based on the results from the use of the BIOLOGICAL RESOURCE. |
Depositor | Kazuhiro Nagata (Kyoto Sangyo University) |
Strain Status | ![]() |
Strain Availability | ![]() |
Additional Info. | Necessary documents for ordering: |
BRC mice in Publications |
---|
No Data |